KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.

MLA

Marrone, Giusi, et al. “KLF2 Exerts Antifibrotic and Vasoprotective Effects in Cirrhotic Rat Livers: Behind the Molecular Mechanisms of Statins.” Gut, vol. 64, no. 9, Sept. 2015, pp. 1434–43. EBSCOhost, https://doi.org/10.1136/gutjnl-2014-308338.

APA

Marrone, G., Maeso-Díaz, R., García-Cardena, G., Abraldes, J. G., García-Pagán, J. C., Bosch, J., & Gracia-Sancho, J. (2015). KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins. Gut, 64(9), 1434–1443. https://doi.org/10.1136/gutjnl-2014-308338

Chicago

Marrone, Giusi, Raquel Maeso-Díaz, Guillermo García-Cardena, Juan G Abraldes, Juan Carlos García-Pagán, Jaime Bosch, and Jordi Gracia-Sancho. 2015. “KLF2 Exerts Antifibrotic and Vasoprotective Effects in Cirrhotic Rat Livers: Behind the Molecular Mechanisms of Statins.” Gut 64 (9): 1434–43. doi:10.1136/gutjnl-2014-308338.